nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—LATS2—brain—meningioma	0.00135	0.00312	CbGeAlD
Sunitinib—PAK3—brain—meningioma	0.00135	0.00312	CbGeAlD
Sunitinib—INSR—cerebellum—meningioma	0.00135	0.00311	CbGeAlD
Sunitinib—OXSR1—cerebellum—meningioma	0.00135	0.00311	CbGeAlD
Sunitinib—SNRK—cerebellum—meningioma	0.00135	0.00311	CbGeAlD
Sunitinib—RPS6KA3—medulla oblongata—meningioma	0.00134	0.00309	CbGeAlD
Sunitinib—STK33—brain—meningioma	0.00133	0.00307	CbGeAlD
Sunitinib—RPS6KA5—brain—meningioma	0.00133	0.00307	CbGeAlD
Sunitinib—STK38—cerebellum—meningioma	0.00133	0.00306	CbGeAlD
Sunitinib—RPS6KA2—cerebellum—meningioma	0.00133	0.00306	CbGeAlD
Sunitinib—CSNK1A1—medulla oblongata—meningioma	0.00131	0.00303	CbGeAlD
Sunitinib—CLK1—medulla oblongata—meningioma	0.00131	0.00301	CbGeAlD
Sunitinib—PKN1—cerebellum—meningioma	0.00131	0.00301	CbGeAlD
Sunitinib—CSNK1G2—cerebellum—meningioma	0.00131	0.00301	CbGeAlD
Sunitinib—TAOK3—brainstem—meningioma	0.0013	0.003	CbGeAlD
Sunitinib—PRPF4—cerebellum—meningioma	0.00129	0.00297	CbGeAlD
Sunitinib—CAMK2G—medulla oblongata—meningioma	0.00128	0.00296	CbGeAlD
Sunitinib—CLK4—brain—meningioma	0.00128	0.00296	CbGeAlD
Sunitinib—LRRK2—medulla oblongata—meningioma	0.00127	0.00293	CbGeAlD
Sunitinib—PRPF4B—cerebellum—meningioma	0.00127	0.00293	CbGeAlD
Sunitinib—SBK1—brain—meningioma	0.00127	0.00292	CbGeAlD
Sunitinib—HIPK4—brain—meningioma	0.00125	0.00289	CbGeAlD
Sunitinib—STK39—cerebellum—meningioma	0.00125	0.00289	CbGeAlD
Sunitinib—PHKG1—brain—meningioma	0.00124	0.00286	CbGeAlD
Sunitinib—DAPK1—brain—meningioma	0.00124	0.00286	CbGeAlD
Sunitinib—CSNK2A1—cerebellum—meningioma	0.00123	0.00285	CbGeAlD
Sunitinib—MAP4K4—spinal cord—meningioma	0.00123	0.00284	CbGeAlD
Sunitinib—MYLK—cerebellum—meningioma	0.00122	0.00281	CbGeAlD
Sunitinib—CSNK1E—medulla oblongata—meningioma	0.00122	0.00281	CbGeAlD
Sunitinib—FGFR1—medulla oblongata—meningioma	0.00122	0.00281	CbGeAlD
Sunitinib—MAP3K12—spinal cord—meningioma	0.00121	0.0028	CbGeAlD
Sunitinib—IRAK4—medulla oblongata—meningioma	0.0012	0.00277	CbGeAlD
Sunitinib—STK11—brain—meningioma	0.0012	0.00277	CbGeAlD
Sunitinib—BRD4—brain—meningioma	0.0012	0.00277	CbGeAlD
Sunitinib—STK4—cerebellum—meningioma	0.0012	0.00276	CbGeAlD
Sunitinib—RPS6KA3—spinal cord—meningioma	0.0012	0.00276	CbGeAlD
Sunitinib—MAP2K1—spinal cord—meningioma	0.00119	0.00274	CbGeAlD
Sunitinib—RPS6KA1—brain—meningioma	0.00119	0.00274	CbGeAlD
Sunitinib—RIOK1—brain—meningioma	0.00119	0.00274	CbGeAlD
Sunitinib—PHKG2—cerebellum—meningioma	0.00118	0.00271	CbGeAlD
Sunitinib—ULK3—medulla oblongata—meningioma	0.00117	0.00271	CbGeAlD
Sunitinib—MAP2K2—medulla oblongata—meningioma	0.00117	0.00271	CbGeAlD
Sunitinib—CSNK1A1—spinal cord—meningioma	0.00117	0.00271	CbGeAlD
Sunitinib—STK24—cerebellum—meningioma	0.00117	0.0027	CbGeAlD
Sunitinib—CLK1—spinal cord—meningioma	0.00117	0.00269	CbGeAlD
Sunitinib—TNIK—brain—meningioma	0.00116	0.00269	CbGeAlD
Sunitinib—MARK2—brain—meningioma	0.00116	0.00269	CbGeAlD
Sunitinib—MAP2K5—brainstem—meningioma	0.00116	0.00269	CbGeAlD
Sunitinib—DAPK2—cerebellum—meningioma	0.00116	0.00267	CbGeAlD
Sunitinib—MAP3K7—medulla oblongata—meningioma	0.00115	0.00266	CbGeAlD
Sunitinib—SGK3—brain—meningioma	0.00115	0.00266	CbGeAlD
Sunitinib—CAMK2G—spinal cord—meningioma	0.00114	0.00264	CbGeAlD
Sunitinib—BMP2K—spinal cord—meningioma	0.00114	0.00264	CbGeAlD
Sunitinib—ICK—brain—meningioma	0.00114	0.00264	CbGeAlD
Sunitinib—TBK1—medulla oblongata—meningioma	0.00114	0.00263	CbGeAlD
Sunitinib—STK16—cerebellum—meningioma	0.00114	0.00262	CbGeAlD
Sunitinib—LRRK2—spinal cord—meningioma	0.00113	0.00261	CbGeAlD
Sunitinib—TYK2—medulla oblongata—meningioma	0.00113	0.00261	CbGeAlD
Sunitinib—HIPK3—cerebellum—meningioma	0.00113	0.00261	CbGeAlD
Sunitinib—HIPK2—cerebellum—meningioma	0.00113	0.00261	CbGeAlD
Sunitinib—TYRO3—cerebellum—meningioma	0.00113	0.00261	CbGeAlD
Sunitinib—RIOK2—cerebellum—meningioma	0.00112	0.00258	CbGeAlD
Sunitinib—TNK1—cerebellum—meningioma	0.00112	0.00258	CbGeAlD
Sunitinib—CHEK2—brain—meningioma	0.0011	0.00255	CbGeAlD
Sunitinib—NUAK1—brain—meningioma	0.0011	0.00255	CbGeAlD
Sunitinib—RPS6KB1—medulla oblongata—meningioma	0.0011	0.00253	CbGeAlD
Sunitinib—INSR—brain—meningioma	0.00109	0.00253	CbGeAlD
Sunitinib—OXSR1—brain—meningioma	0.00109	0.00253	CbGeAlD
Sunitinib—SNRK—brain—meningioma	0.00109	0.00253	CbGeAlD
Sunitinib—RET—medulla oblongata—meningioma	0.00109	0.00252	CbGeAlD
Sunitinib—FGFR1—spinal cord—meningioma	0.00109	0.00251	CbGeAlD
Sunitinib—CSNK1E—spinal cord—meningioma	0.00109	0.00251	CbGeAlD
Sunitinib—DAPK3—cerebellum—meningioma	0.00109	0.00251	CbGeAlD
Sunitinib—AXL—medulla oblongata—meningioma	0.00109	0.00251	CbGeAlD
Sunitinib—RPS6KA2—brain—meningioma	0.00108	0.00249	CbGeAlD
Sunitinib—STK38—brain—meningioma	0.00108	0.00249	CbGeAlD
Sunitinib—CLK2—cerebellum—meningioma	0.00108	0.00248	CbGeAlD
Sunitinib—MAP4K2—cerebellum—meningioma	0.00107	0.00247	CbGeAlD
Sunitinib—IRAK4—spinal cord—meningioma	0.00107	0.00247	CbGeAlD
Sunitinib—AURKC—brain—meningioma	0.00107	0.00247	CbGeAlD
Sunitinib—PKN1—brain—meningioma	0.00106	0.00245	CbGeAlD
Sunitinib—CSNK1G2—brain—meningioma	0.00106	0.00245	CbGeAlD
Sunitinib—STK3—cerebellum—meningioma	0.00106	0.00244	CbGeAlD
Sunitinib—MAP2K2—spinal cord—meningioma	0.00105	0.00241	CbGeAlD
Sunitinib—ULK3—spinal cord—meningioma	0.00105	0.00241	CbGeAlD
Sunitinib—SLK—medulla oblongata—meningioma	0.00105	0.00241	CbGeAlD
Sunitinib—PRPF4—brain—meningioma	0.00105	0.00241	CbGeAlD
Sunitinib—KIT—brainstem—meningioma	0.00103	0.00238	CbGeAlD
Sunitinib—JAK2—medulla oblongata—meningioma	0.00103	0.00238	CbGeAlD
Sunitinib—PRPF4B—brain—meningioma	0.00103	0.00238	CbGeAlD
Sunitinib—MAP3K7—spinal cord—meningioma	0.00103	0.00237	CbGeAlD
Sunitinib—DYRK1A—cerebellum—meningioma	0.00102	0.00235	CbGeAlD
Sunitinib—TBK1—spinal cord—meningioma	0.00102	0.00235	CbGeAlD
Sunitinib—FYN—medulla oblongata—meningioma	0.00102	0.00235	CbGeAlD
Sunitinib—STK39—brain—meningioma	0.00102	0.00234	CbGeAlD
Sunitinib—TYK2—spinal cord—meningioma	0.00101	0.00233	CbGeAlD
Sunitinib—CSNK2A1—brain—meningioma	0.001	0.00231	CbGeAlD
Sunitinib—MERTK—cerebellum—meningioma	0.000994	0.00229	CbGeAlD
Sunitinib—MAP4K5—medulla oblongata—meningioma	0.000993	0.00229	CbGeAlD
Sunitinib—MAP3K3—medulla oblongata—meningioma	0.000993	0.00229	CbGeAlD
Sunitinib—MYLK—brain—meningioma	0.00099	0.00228	CbGeAlD
Sunitinib—RPS6KB1—spinal cord—meningioma	0.000978	0.00226	CbGeAlD
Sunitinib—PLK4—brain—meningioma	0.000978	0.00226	CbGeAlD
Sunitinib—MAP4K4—cerebellum—meningioma	0.000975	0.00225	CbGeAlD
Sunitinib—RET—spinal cord—meningioma	0.000972	0.00224	CbGeAlD
Sunitinib—STK4—brain—meningioma	0.000972	0.00224	CbGeAlD
Sunitinib—AXL—spinal cord—meningioma	0.000968	0.00223	CbGeAlD
Sunitinib—NUAK2—cerebellum—meningioma	0.000968	0.00223	CbGeAlD
Sunitinib—MAP3K12—cerebellum—meningioma	0.000962	0.00222	CbGeAlD
Sunitinib—FLT3—cerebellum—meningioma	0.000962	0.00222	CbGeAlD
Sunitinib—FLT1—medulla oblongata—meningioma	0.00096	0.00222	CbGeAlD
Sunitinib—PHKG2—brain—meningioma	0.000955	0.0022	CbGeAlD
Sunitinib—EPHB6—medulla oblongata—meningioma	0.000949	0.00219	CbGeAlD
Sunitinib—STK24—brain—meningioma	0.000949	0.00219	CbGeAlD
Sunitinib—RPS6KA3—cerebellum—meningioma	0.000948	0.00219	CbGeAlD
Sunitinib—MAP2K1—cerebellum—meningioma	0.000942	0.00217	CbGeAlD
Sunitinib—DAPK2—brain—meningioma	0.000939	0.00217	CbGeAlD
Sunitinib—SLK—spinal cord—meningioma	0.000932	0.00215	CbGeAlD
Sunitinib—CSNK1A1—cerebellum—meningioma	0.00093	0.00214	CbGeAlD
Sunitinib—FGFR2—spinal cord—meningioma	0.000924	0.00213	CbGeAlD
Sunitinib—CLK1—cerebellum—meningioma	0.000924	0.00213	CbGeAlD
Sunitinib—STK16—brain—meningioma	0.000923	0.00213	CbGeAlD
Sunitinib—JAK2—spinal cord—meningioma	0.000919	0.00212	CbGeAlD
Sunitinib—HIPK2—brain—meningioma	0.000919	0.00212	CbGeAlD
Sunitinib—HIPK3—brain—meningioma	0.000919	0.00212	CbGeAlD
Sunitinib—ALK—brain—meningioma	0.000919	0.00212	CbGeAlD
Sunitinib—TYRO3—brain—meningioma	0.000919	0.00212	CbGeAlD
Sunitinib—YES1—medulla oblongata—meningioma	0.000917	0.00212	CbGeAlD
Sunitinib—RIOK2—brain—meningioma	0.000909	0.0021	CbGeAlD
Sunitinib—TNK1—brain—meningioma	0.000909	0.0021	CbGeAlD
Sunitinib—BMP2K—cerebellum—meningioma	0.000907	0.00209	CbGeAlD
Sunitinib—CAMK2G—cerebellum—meningioma	0.000907	0.00209	CbGeAlD
Sunitinib—FYN—spinal cord—meningioma	0.000906	0.00209	CbGeAlD
Sunitinib—TAOK3—medulla oblongata—meningioma	0.000906	0.00209	CbGeAlD
Sunitinib—MAP3K19—brain—meningioma	0.0009	0.00208	CbGeAlD
Sunitinib—MAP4K1—brain—meningioma	0.0009	0.00208	CbGeAlD
Sunitinib—LRRK2—cerebellum—meningioma	0.000899	0.00207	CbGeAlD
Sunitinib—MAP4K5—spinal cord—meningioma	0.000886	0.00204	CbGeAlD
Sunitinib—MAP3K3—spinal cord—meningioma	0.000886	0.00204	CbGeAlD
Sunitinib—PRKAA1—cerebellum—meningioma	0.000886	0.00204	CbGeAlD
Sunitinib—DAPK3—brain—meningioma	0.000883	0.00204	CbGeAlD
Sunitinib—PTK2B—cerebellum—meningioma	0.000876	0.00202	CbGeAlD
Sunitinib—CLK2—brain—meningioma	0.000874	0.00202	CbGeAlD
Sunitinib—MAP4K2—brain—meningioma	0.00087	0.00201	CbGeAlD
Sunitinib—CSNK1E—cerebellum—meningioma	0.000862	0.00199	CbGeAlD
Sunitinib—FGFR1—cerebellum—meningioma	0.000862	0.00199	CbGeAlD
Sunitinib—STK3—brain—meningioma	0.000858	0.00198	CbGeAlD
Sunitinib—FLT1—spinal cord—meningioma	0.000856	0.00198	CbGeAlD
Sunitinib—IRAK4—cerebellum—meningioma	0.000848	0.00196	CbGeAlD
Sunitinib—ROCK1—brain—meningioma	0.000847	0.00195	CbGeAlD
Sunitinib—EPHB6—spinal cord—meningioma	0.000847	0.00195	CbGeAlD
Sunitinib—MAP2K2—cerebellum—meningioma	0.000829	0.00191	CbGeAlD
Sunitinib—ULK3—cerebellum—meningioma	0.000829	0.00191	CbGeAlD
Sunitinib—DYRK1A—brain—meningioma	0.000826	0.00191	CbGeAlD
Sunitinib—MAP3K2—cerebellum—meningioma	0.000823	0.0019	CbGeAlD
Sunitinib—YES1—spinal cord—meningioma	0.000818	0.00189	CbGeAlD
Sunitinib—MAP3K7—cerebellum—meningioma	0.000816	0.00188	CbGeAlD
Sunitinib—KDR—medulla oblongata—meningioma	0.000812	0.00187	CbGeAlD
Sunitinib—MAP2K5—medulla oblongata—meningioma	0.000812	0.00187	CbGeAlD
Sunitinib—TAOK3—spinal cord—meningioma	0.000808	0.00186	CbGeAlD
Sunitinib—MERTK—brain—meningioma	0.000807	0.00186	CbGeAlD
Sunitinib—TBK1—cerebellum—meningioma	0.000806	0.00186	CbGeAlD
Sunitinib—PDGFRA—spinal cord—meningioma	0.000803	0.00185	CbGeAlD
Sunitinib—TYK2—cerebellum—meningioma	0.000801	0.00185	CbGeAlD
Sunitinib—CSF1R—medulla oblongata—meningioma	0.000792	0.00183	CbGeAlD
Sunitinib—MAP4K4—brain—meningioma	0.000792	0.00183	CbGeAlD
Sunitinib—IRAK1—cerebellum—meningioma	0.000791	0.00182	CbGeAlD
Sunitinib—NUAK2—brain—meningioma	0.000787	0.00181	CbGeAlD
Sunitinib—MAP3K12—brain—meningioma	0.000781	0.0018	CbGeAlD
Sunitinib—RPS6KB1—cerebellum—meningioma	0.000776	0.00179	CbGeAlD
Sunitinib—RET—cerebellum—meningioma	0.000771	0.00178	CbGeAlD
Sunitinib—RPS6KA3—brain—meningioma	0.00077	0.00178	CbGeAlD
Sunitinib—AXL—cerebellum—meningioma	0.000768	0.00177	CbGeAlD
Sunitinib—MAP2K1—brain—meningioma	0.000765	0.00177	CbGeAlD
Sunitinib—CSNK1A1—brain—meningioma	0.000755	0.00174	CbGeAlD
Sunitinib—CLK1—brain—meningioma	0.00075	0.00173	CbGeAlD
Sunitinib—SLK—cerebellum—meningioma	0.000739	0.00171	CbGeAlD
Sunitinib—CAMK2G—brain—meningioma	0.000737	0.0017	CbGeAlD
Sunitinib—BMP2K—brain—meningioma	0.000737	0.0017	CbGeAlD
Sunitinib—FGFR2—cerebellum—meningioma	0.000733	0.00169	CbGeAlD
Sunitinib—LRRK2—brain—meningioma	0.00073	0.00168	CbGeAlD
Sunitinib—JAK2—cerebellum—meningioma	0.000729	0.00168	CbGeAlD
Sunitinib—KDR—spinal cord—meningioma	0.000724	0.00167	CbGeAlD
Sunitinib—MAP2K5—spinal cord—meningioma	0.000724	0.00167	CbGeAlD
Sunitinib—KIT—medulla oblongata—meningioma	0.000719	0.00166	CbGeAlD
Sunitinib—PRKAA1—brain—meningioma	0.000719	0.00166	CbGeAlD
Sunitinib—FYN—cerebellum—meningioma	0.000719	0.00166	CbGeAlD
Sunitinib—PTK2B—brain—meningioma	0.000711	0.00164	CbGeAlD
Sunitinib—FLT4—brain—meningioma	0.000709	0.00164	CbGeAlD
Sunitinib—CSF1R—spinal cord—meningioma	0.000707	0.00163	CbGeAlD
Sunitinib—PDGFRB—medulla oblongata—meningioma	0.000703	0.00162	CbGeAlD
Sunitinib—MAP4K5—cerebellum—meningioma	0.000702	0.00162	CbGeAlD
Sunitinib—MAP3K3—cerebellum—meningioma	0.000702	0.00162	CbGeAlD
Sunitinib—CSNK1E—brain—meningioma	0.0007	0.00161	CbGeAlD
Sunitinib—FGFR1—brain—meningioma	0.0007	0.00161	CbGeAlD
Sunitinib—IRAK4—brain—meningioma	0.000689	0.00159	CbGeAlD
Sunitinib—FLT1—cerebellum—meningioma	0.000679	0.00157	CbGeAlD
Sunitinib—ULK3—brain—meningioma	0.000674	0.00155	CbGeAlD
Sunitinib—MAP2K2—brain—meningioma	0.000674	0.00155	CbGeAlD
Sunitinib—EPHB6—cerebellum—meningioma	0.000671	0.00155	CbGeAlD
Sunitinib—MAP3K2—brain—meningioma	0.000669	0.00154	CbGeAlD
Sunitinib—MAP3K7—brain—meningioma	0.000663	0.00153	CbGeAlD
Sunitinib—TBK1—brain—meningioma	0.000655	0.00151	CbGeAlD
Sunitinib—TYK2—brain—meningioma	0.000651	0.0015	CbGeAlD
Sunitinib—YES1—cerebellum—meningioma	0.000649	0.0015	CbGeAlD
Sunitinib—STK10—cerebellum—meningioma	0.000643	0.00148	CbGeAlD
Sunitinib—IRAK1—brain—meningioma	0.000642	0.00148	CbGeAlD
Sunitinib—KIT—spinal cord—meningioma	0.000642	0.00148	CbGeAlD
Sunitinib—TAOK3—cerebellum—meningioma	0.00064	0.00148	CbGeAlD
Sunitinib—PDGFRA—cerebellum—meningioma	0.000636	0.00147	CbGeAlD
Sunitinib—RPS6KB1—brain—meningioma	0.00063	0.00145	CbGeAlD
Sunitinib—PDGFRB—spinal cord—meningioma	0.000627	0.00145	CbGeAlD
Sunitinib—RET—brain—meningioma	0.000626	0.00144	CbGeAlD
Sunitinib—FGR—brain—meningioma	0.000626	0.00144	CbGeAlD
Sunitinib—AXL—brain—meningioma	0.000624	0.00144	CbGeAlD
Sunitinib—SLK—brain—meningioma	0.0006	0.00139	CbGeAlD
Sunitinib—FGFR2—brain—meningioma	0.000595	0.00137	CbGeAlD
Sunitinib—JAK2—brain—meningioma	0.000592	0.00137	CbGeAlD
Sunitinib—FYN—brain—meningioma	0.000584	0.00135	CbGeAlD
Sunitinib—KDR—cerebellum—meningioma	0.000574	0.00132	CbGeAlD
Sunitinib—MAP2K5—cerebellum—meningioma	0.000574	0.00132	CbGeAlD
Sunitinib—MAP3K3—brain—meningioma	0.000571	0.00132	CbGeAlD
Sunitinib—MAP4K5—brain—meningioma	0.000571	0.00132	CbGeAlD
Sunitinib—CSF1R—cerebellum—meningioma	0.00056	0.00129	CbGeAlD
Sunitinib—FLT1—brain—meningioma	0.000552	0.00127	CbGeAlD
Sunitinib—EPHB6—brain—meningioma	0.000545	0.00126	CbGeAlD
Sunitinib—YES1—brain—meningioma	0.000527	0.00122	CbGeAlD
Sunitinib—STK10—brain—meningioma	0.000522	0.0012	CbGeAlD
Sunitinib—TAOK3—brain—meningioma	0.00052	0.0012	CbGeAlD
Sunitinib—PDGFRA—brain—meningioma	0.000517	0.00119	CbGeAlD
Sunitinib—KIT—cerebellum—meningioma	0.000509	0.00117	CbGeAlD
Sunitinib—PDGFRB—cerebellum—meningioma	0.000497	0.00115	CbGeAlD
Sunitinib—KDR—brain—meningioma	0.000466	0.00108	CbGeAlD
Sunitinib—MAP2K5—brain—meningioma	0.000466	0.00108	CbGeAlD
Sunitinib—CSF1R—brain—meningioma	0.000455	0.00105	CbGeAlD
Sunitinib—KCNH2—medulla oblongata—meningioma	0.000444	0.00102	CbGeAlD
Sunitinib—KIT—brain—meningioma	0.000413	0.000953	CbGeAlD
Sunitinib—PDGFRB—brain—meningioma	0.000404	0.000931	CbGeAlD
Sunitinib—KCNH2—spinal cord—meningioma	0.000396	0.000913	CbGeAlD
Sunitinib—ABCG2—medulla oblongata—meningioma	0.000395	0.000911	CbGeAlD
Sunitinib—ABCG2—spinal cord—meningioma	0.000352	0.000812	CbGeAlD
Sunitinib—ABCC4—brain—meningioma	0.000321	0.000741	CbGeAlD
Sunitinib—KCNH2—cerebellum—meningioma	0.000314	0.000724	CbGeAlD
Sunitinib—ABCG2—cerebellum—meningioma	0.000279	0.000644	CbGeAlD
Sunitinib—KCNH2—brain—meningioma	0.000255	0.000588	CbGeAlD
Sunitinib—ABCG2—brain—meningioma	0.000227	0.000523	CbGeAlD
Sunitinib—ABCB1—medulla oblongata—meningioma	0.000195	0.000449	CbGeAlD
Sunitinib—ABCB1—spinal cord—meningioma	0.000174	0.000401	CbGeAlD
Sunitinib—ABCB1—cerebellum—meningioma	0.000138	0.000318	CbGeAlD
Sunitinib—ABCB1—brain—meningioma	0.000112	0.000258	CbGeAlD
Sunitinib—MAP2K2—Signaling Pathways—HES1—meningioma	2.79e-05	4.93e-05	CbGpPWpGaD
Sunitinib—TYK2—Developmental Biology—AKT1—meningioma	2.79e-05	4.93e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PDGFB—meningioma	2.78e-05	4.91e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—TP53—meningioma	2.77e-05	4.89e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—TP53—meningioma	2.77e-05	4.89e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PDGFB—meningioma	2.73e-05	4.83e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PDGFB—meningioma	2.73e-05	4.83e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—HES1—meningioma	2.73e-05	4.81e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Immune System—AKT1—meningioma	2.72e-05	4.8e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—PTEN—meningioma	2.71e-05	4.78e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—ERBB2—meningioma	2.7e-05	4.76e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—ERBB2—meningioma	2.69e-05	4.75e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—TP53—meningioma	2.69e-05	4.74e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—ERBB2—meningioma	2.68e-05	4.74e-05	CbGpPWpGaD
Sunitinib—YES1—Innate Immune System—AKT1—meningioma	2.68e-05	4.73e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Disease—AKT1—meningioma	2.67e-05	4.71e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—ERBB2—meningioma	2.66e-05	4.7e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—HES1—meningioma	2.63e-05	4.64e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—ERBB2—meningioma	2.62e-05	4.62e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—PTEN—meningioma	2.62e-05	4.62e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—HES1—meningioma	2.61e-05	4.61e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—ERBB2—meningioma	2.61e-05	4.61e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PDGFB—meningioma	2.6e-05	4.58e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PDGFB—meningioma	2.59e-05	4.57e-05	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—TP53—meningioma	2.59e-05	4.57e-05	CbGpPWpGaD
Sunitinib—YES1—Adaptive Immune System—AKT1—meningioma	2.57e-05	4.54e-05	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—AKT1—meningioma	2.57e-05	4.54e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—PTEN—meningioma	2.57e-05	4.53e-05	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—AKT1—meningioma	2.56e-05	4.52e-05	CbGpPWpGaD
Sunitinib—IRAK1—Innate Immune System—AKT1—meningioma	2.54e-05	4.48e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—ERBB2—meningioma	2.52e-05	4.44e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Metabolism—AKT1—meningioma	2.5e-05	4.42e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—ERBB2—meningioma	2.5e-05	4.42e-05	CbGpPWpGaD
Sunitinib—TBK1—Immune System—AKT1—meningioma	2.5e-05	4.41e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—HES1—meningioma	2.5e-05	4.41e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—PTEN—meningioma	2.49e-05	4.4e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—ERBB2—meningioma	2.48e-05	4.38e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—TP53—meningioma	2.48e-05	4.38e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—ERBB2—meningioma	2.48e-05	4.37e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—ERBB2—meningioma	2.48e-05	4.37e-05	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—AKT1—meningioma	2.47e-05	4.35e-05	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—AKT1—meningioma	2.46e-05	4.35e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—PTEN—meningioma	2.46e-05	4.34e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—TSHB—meningioma	2.46e-05	4.34e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	2.46e-05	4.34e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—TP53—meningioma	2.46e-05	4.34e-05	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—AKT1—meningioma	2.45e-05	4.33e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—PTEN—meningioma	2.45e-05	4.33e-05	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—AKT1—meningioma	2.44e-05	4.3e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—PTEN—meningioma	2.43e-05	4.29e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—ERBB2—meningioma	2.43e-05	4.28e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—ERBB2—meningioma	2.43e-05	4.28e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—ERBB2—meningioma	2.42e-05	4.27e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—PTEN—meningioma	2.42e-05	4.27e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—PTEN—meningioma	2.42e-05	4.27e-05	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—AKT1—meningioma	2.4e-05	4.24e-05	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—AKT1—meningioma	2.4e-05	4.23e-05	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—AKT1—meningioma	2.39e-05	4.22e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—AKT1—meningioma	2.39e-05	4.22e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PDGFB—meningioma	2.39e-05	4.22e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—AKT1—meningioma	2.37e-05	4.19e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—AKT1—meningioma	2.37e-05	4.18e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—ERBB2—meningioma	2.36e-05	4.17e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALAD—meningioma	2.35e-05	4.15e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—TP53—meningioma	2.34e-05	4.14e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—AKT1—meningioma	2.34e-05	4.13e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—AKT1—meningioma	2.34e-05	4.13e-05	CbGpPWpGaD
Sunitinib—FGFR2—Adaptive Immune System—AKT1—meningioma	2.34e-05	4.13e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PDGFB—meningioma	2.33e-05	4.12e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—ERBB2—meningioma	2.33e-05	4.11e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—TP53—meningioma	2.32e-05	4.09e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—ERBB2—meningioma	2.32e-05	4.09e-05	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—AKT1—meningioma	2.31e-05	4.07e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—PTEN—meningioma	2.3e-05	4.06e-05	CbGpPWpGaD
Sunitinib—KIT—Adaptive Immune System—AKT1—meningioma	2.3e-05	4.05e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Adaptive Immune System—AKT1—meningioma	2.3e-05	4.05e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—PTEN—meningioma	2.29e-05	4.05e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—PTEN—meningioma	2.29e-05	4.04e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—ERBB2—meningioma	2.29e-05	4.04e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—PTEN—meningioma	2.27e-05	4.01e-05	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—AKT1—meningioma	2.27e-05	4.01e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—AKT1—meningioma	2.27e-05	4.01e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—AKT1—meningioma	2.26e-05	4e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PDGFB—meningioma	2.25e-05	3.97e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PDGFB—meningioma	2.24e-05	3.95e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—ERBB2—meningioma	2.23e-05	3.94e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—PTEN—meningioma	2.23e-05	3.94e-05	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—AKT1—meningioma	2.23e-05	3.93e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—PTEN—meningioma	2.23e-05	3.93e-05	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—AKT1—meningioma	2.23e-05	3.93e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—ERBB2—meningioma	2.22e-05	3.91e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—AKT1—meningioma	2.21e-05	3.91e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—TP53—meningioma	2.21e-05	3.9e-05	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—AKT1—meningioma	2.18e-05	3.86e-05	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—AKT1—meningioma	2.18e-05	3.85e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—AKT1—meningioma	2.17e-05	3.84e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—AKT1—meningioma	2.17e-05	3.83e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—AKT1—meningioma	2.15e-05	3.8e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—ERBB2—meningioma	2.15e-05	3.8e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—PTEN—meningioma	2.15e-05	3.79e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—ERBB2—meningioma	2.14e-05	3.78e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PDGFB—meningioma	2.14e-05	3.77e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—PTEN—meningioma	2.13e-05	3.77e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—PTEN—meningioma	2.12e-05	3.74e-05	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—AKT1—meningioma	2.12e-05	3.74e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—PTEN—meningioma	2.11e-05	3.73e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—PTEN—meningioma	2.11e-05	3.73e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—AKT1—meningioma	2.09e-05	3.7e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—AKT1—meningioma	2.09e-05	3.7e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—AKT1—meningioma	2.09e-05	3.69e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—TP53—meningioma	2.08e-05	3.68e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	2.08e-05	3.67e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—AKT1—meningioma	2.08e-05	3.66e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—PTEN—meningioma	2.07e-05	3.65e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—PTEN—meningioma	2.07e-05	3.65e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—TP53—meningioma	2.07e-05	3.65e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—PTEN—meningioma	2.06e-05	3.64e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—ERBB2—meningioma	2.05e-05	3.62e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—ERBB2—meningioma	2.05e-05	3.61e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—AKT1—meningioma	2.04e-05	3.6e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—PTEN—meningioma	2.02e-05	3.56e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—PTEN—meningioma	1.99e-05	3.51e-05	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—AKT1—meningioma	1.99e-05	3.51e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—AKT1—meningioma	1.98e-05	3.49e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—PTEN—meningioma	1.98e-05	3.49e-05	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—AKT1—meningioma	1.97e-05	3.47e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—AKT1—meningioma	1.96e-05	3.46e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—AKT1—meningioma	1.96e-05	3.46e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—AKT1—meningioma	1.96e-05	3.45e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—PTEN—meningioma	1.95e-05	3.44e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—ERBB2—meningioma	1.95e-05	3.44e-05	CbGpPWpGaD
Sunitinib—BLK—Immune System—AKT1—meningioma	1.94e-05	3.42e-05	CbGpPWpGaD
Sunitinib—FGR—Immune System—AKT1—meningioma	1.93e-05	3.41e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—PTEN—meningioma	1.9e-05	3.36e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—ERBB2—meningioma	1.89e-05	3.34e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—PTEN—meningioma	1.89e-05	3.33e-05	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—AKT1—meningioma	1.89e-05	3.33e-05	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—AKT1—meningioma	1.87e-05	3.3e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—AKT1—meningioma	1.87e-05	3.29e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—ERBB2—meningioma	1.87e-05	3.29e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—PTEN—meningioma	1.83e-05	3.24e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—ERBB2—meningioma	1.83e-05	3.24e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—ERBB2—meningioma	1.83e-05	3.24e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PTEN—meningioma	1.82e-05	3.22e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TP53—meningioma	1.79e-05	3.15e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—AKT1—meningioma	1.76e-05	3.11e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—PTEN—meningioma	1.75e-05	3.09e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—AKT1—meningioma	1.75e-05	3.08e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—PTEN—meningioma	1.74e-05	3.08e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—ERBB2—meningioma	1.74e-05	3.07e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—ERBB2—meningioma	1.73e-05	3.06e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TP53—meningioma	1.68e-05	2.96e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TP53—meningioma	1.66e-05	2.93e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—PTEN—meningioma	1.66e-05	2.93e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—PTEN—meningioma	1.61e-05	2.84e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—ERBB2—meningioma	1.6e-05	2.83e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PTEN—meningioma	1.59e-05	2.81e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—AKT1—meningioma	1.57e-05	2.77e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—ERBB2—meningioma	1.56e-05	2.76e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PTEN—meningioma	1.56e-05	2.76e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PTEN—meningioma	1.56e-05	2.76e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—AKT1—meningioma	1.56e-05	2.75e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TP53—meningioma	1.52e-05	2.69e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TSHB—meningioma	1.52e-05	2.67e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—AKT1—meningioma	1.51e-05	2.66e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—ERBB2—meningioma	1.51e-05	2.66e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—ERBB2—meningioma	1.5e-05	2.65e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PTEN—meningioma	1.48e-05	2.62e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—AKT1—meningioma	1.48e-05	2.61e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PTEN—meningioma	1.48e-05	2.61e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—meningioma	1.47e-05	2.59e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—meningioma	1.46e-05	2.57e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—AKT1—meningioma	1.44e-05	2.54e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—ERBB2—meningioma	1.43e-05	2.53e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—AKT1—meningioma	1.42e-05	2.5e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—AKT1—meningioma	1.41e-05	2.5e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—meningioma	1.41e-05	2.49e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—meningioma	1.41e-05	2.49e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—AKT1—meningioma	1.4e-05	2.47e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—AKT1—meningioma	1.39e-05	2.46e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—AKT1—meningioma	1.39e-05	2.46e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—meningioma	1.38e-05	2.43e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PTEN—meningioma	1.37e-05	2.41e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PTEN—meningioma	1.33e-05	2.35e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—AKT1—meningioma	1.33e-05	2.35e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—AKT1—meningioma	1.33e-05	2.34e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—AKT1—meningioma	1.32e-05	2.33e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—AKT1—meningioma	1.32e-05	2.33e-05	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—AKT1—meningioma	1.31e-05	2.32e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—AKT1—meningioma	1.31e-05	2.31e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—AKT1—meningioma	1.29e-05	2.27e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PTEN—meningioma	1.28e-05	2.27e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—AKT1—meningioma	1.28e-05	2.27e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PTEN—meningioma	1.28e-05	2.26e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AKT1—meningioma	1.25e-05	2.2e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTEN—meningioma	1.24e-05	2.19e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AKT1—meningioma	1.24e-05	2.18e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AKT1—meningioma	1.23e-05	2.17e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTEN—meningioma	1.23e-05	2.17e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PTEN—meningioma	1.22e-05	2.16e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—AKT1—meningioma	1.22e-05	2.15e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—AKT1—meningioma	1.22e-05	2.15e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—AKT1—meningioma	1.22e-05	2.15e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—meningioma	1.19e-05	2.11e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AKT1—meningioma	1.19e-05	2.1e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AKT1—meningioma	1.19e-05	2.1e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AKT1—meningioma	1.19e-05	2.1e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—AKT1—meningioma	1.19e-05	2.1e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AKT1—meningioma	1.16e-05	2.05e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—AKT1—meningioma	1.15e-05	2.02e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—AKT1—meningioma	1.14e-05	2.01e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—meningioma	1.13e-05	2e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—AKT1—meningioma	1.12e-05	1.98e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—meningioma	1.1e-05	1.94e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—AKT1—meningioma	1.1e-05	1.94e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—AKT1—meningioma	1.09e-05	1.92e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—meningioma	1.09e-05	1.92e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—meningioma	1.07e-05	1.88e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—meningioma	1.07e-05	1.88e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—AKT1—meningioma	1.06e-05	1.87e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—AKT1—meningioma	1.05e-05	1.86e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—meningioma	1.01e-05	1.79e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—meningioma	1.01e-05	1.78e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AKT1—meningioma	1.01e-05	1.78e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—AKT1—meningioma	1.01e-05	1.77e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AKT1—meningioma	9.57e-06	1.69e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—meningioma	9.32e-06	1.65e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AKT1—meningioma	9.29e-06	1.64e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AKT1—meningioma	9.17e-06	1.62e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—meningioma	9.1e-06	1.61e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AKT1—meningioma	9.01e-06	1.59e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AKT1—meningioma	9.01e-06	1.59e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTEN—meningioma	8.88e-06	1.57e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—meningioma	8.77e-06	1.55e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—meningioma	8.72e-06	1.54e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AKT1—meningioma	8.55e-06	1.51e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AKT1—meningioma	8.53e-06	1.51e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—meningioma	8.33e-06	1.47e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AKT1—meningioma	7.87e-06	1.39e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AKT1—meningioma	7.68e-06	1.36e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AKT1—meningioma	7.4e-06	1.31e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AKT1—meningioma	7.36e-06	1.3e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AKT1—meningioma	7.14e-06	1.26e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AKT1—meningioma	7.08e-06	1.25e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AKT1—meningioma	7.04e-06	1.24e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTEN—meningioma	6.7e-06	1.18e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AKT1—meningioma	5.12e-06	9.03e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTEN—meningioma	4.13e-06	7.29e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AKT1—meningioma	3.86e-06	6.82e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKT1—meningioma	2.38e-06	4.2e-06	CbGpPWpGaD
